Rate My Professor Syafiq Asnawi

Currently, Dr. Asnawi directs the Monash University Malaysia Proteomics and Metabolomics Platform (MUMPMP). His research specializations include venomics of snake venom and jellyfish, anti-cancer therapeutics, anti-venom research, liquid chromatography-mass spectrometry, proteomics, and metabolomics. He has obtained significant funding as principal investigator for the Fundamental Research Grant Scheme from the Ministry of Higher Education Malaysia, co-investigator in a Wellcome Trust UK-funded project, and principal investigator for a grant from the Royal Society of Tropical Medicine and Hygiene-Wellcome Trust UK. Awards include the Three Minutes Thesis Winner in 2016 and Faculty Level Finalist. Key publications encompass 'Shotgun Proteomics and Mass Spectrometry as a Tool for Protein Identification and Profiling of Bio-Carrier-Based Therapeutics on Human Cancer Cells' (2021), 'Antiviral potential of diosmin against influenza A virus' (2025), 'Comparative venom proteomes of Malaysian snake species from regions in Southeast Asia obtained by shotgun proteomics: A systematic review' (2025), 'Consolidation of venom proteomes from major Cnidarian species (Scyphozoa and Cubozoa) obtained using liquid chromatography-tandem mass spectrometry' (2025), and 'Fabrication and characterization of calcium carbonate nanoparticles for delivery of doxorubicin in breast cancer cells' (2025). He teaches Biochemistry and Biomedical Science units, coordinates student projects, and supervises PhD students in natural product anticancer agents and antivenom research. His contributions support UN Sustainable Development Goals 3 and 14 and have appeared in media on snakebite management and venom-based cancer therapies.